Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease

Details for Australian Patent Application No. 2009202023 (hide)

Owner Proteotech, Inc.

Inventors Coffen, David L.; Snow, Alan D.; Lake, Thomas P.; Sanders, Virginia J.; Lorimer, Stephen D.; Larsen, David S.; Weavers, Rex T.; Larsen, Lesley; Castillo, Gerardo M.; Nguyen, Beth P.

Agent Spruson & Ferguson

Pub. Number AU-B-2009202023

Parent 2003249678

Filing date 21 May 2009

Wipo publication date 11 June 2009

Acceptance publication date 7 April 2011

International Classifications

C07D 295/08 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/05 (2006.01)

A61K 31/121 (2006.01) - acyclic

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/4375 (2006.01)

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 37/055 (2006.01) Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring

C07C 39/15 (2006.01) Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring

C07C 39/16 (2006.01) Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring

C07C 39/17 (2006.01) Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring

C07C 45/62 (2006.01) Preparation of compounds having CO groups bound only to carbon or hydrogen atoms

Event Publications

11 June 2009 Application Open to Public Inspection

  Published as AU-B-2009202023

11 June 2009 Complete Application Filed

7 April 2011 Application Accepted

  Published as AU-B-2009202023

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009202024-Washing machine and method of controlling a washing machine

2009202022-Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease